Literature DB >> 29601902

Rethinking What We Know About Hemorrhoids.

Robert S Sandler1, Anne F Peery2.   

Abstract

Although hemorrhoids are responsible for considerable economic cost and personal suffering, they have received surprisingly little research attention. In the United States, hemorrhoids are the third most common outpatient gastrointestinal diagnosis with nearly 4 million office and emergency department visits annually. The etiology of hemorrhoids is speculative. A low-fiber diet and constipation have historically been thought to increase the risk for hemorrhoids, but not proven. Symptoms commonly attributed to hemorrhoids include bleeding, pain, pruritus, fecal seepage, prolapse, and mucus discharge. Research has found that these symptoms were equally reported by patients with and without hemorrhoids. Medical therapies for hemorrhoids have not been formally studied except for fiber where the results have been inconsistent. A number of office-based interventions such as rubber band ligation and infrared coagulation are widely used and economically favorable for practitioners. Surgical procedures are effective at eliminating hemorrhoids but may be painful. Given the burden of disease and numerous gaps in our understanding, the time has come for targeted research to understand the cause, symptoms, and best treatment for patients with symptomatic hemorrhoids.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hemorrhoids; Patient-Reported Outcome; Prevalence; Review

Mesh:

Year:  2018        PMID: 29601902      PMCID: PMC7075634          DOI: 10.1016/j.cgh.2018.03.020

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  50 in total

1.  The prevalence of hemorrhoids in adults.

Authors:  Stefan Riss; Friedrich Anton Weiser; Katrin Schwameis; Thomas Riss; Martina Mittlböck; Gottfried Steiner; Anton Stift
Journal:  Int J Colorectal Dis       Date:  2011-09-20       Impact factor: 2.571

2.  Impact of the aging population on the demand for colorectal procedures.

Authors:  David A Etzioni; Robert W Beart; Robert D Madoff; Glenn T Ault
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

3.  Associations between hemorrhoids and other diagnoses.

Authors:  F Delcò; A Sonnenberg
Journal:  Dis Colon Rectum       Date:  1998-12       Impact factor: 4.585

4.  Comparison of hemorrhoidal treatments: a meta-analysis.

Authors:  H M MacRae; R S McLeod
Journal:  Can J Surg       Date:  1997-02       Impact factor: 2.089

5.  ACG clinical guideline: management of benign anorectal disorders.

Authors:  Arnold Wald; Adil E Bharucha; Bard C Cosman; William E Whitehead
Journal:  Am J Gastroenterol       Date:  2014-07-15       Impact factor: 10.864

Review 6.  Devices for the endoscopic treatment of hemorrhoids.

Authors:  Uzma D Siddiqui; Bradley A Barth; Subhas Banerjee; Yasser M Bhat; Shailendra S Chauhan; Klaus T Gottlieb; Vani Konda; John T Maple; Faris M Murad; Patrick Pfau; Douglas Pleskow; Jeffrey L Tokar; Amy Wang; Sarah A Rodriguez
Journal:  Gastrointest Endosc       Date:  2013-11-14       Impact factor: 9.427

7.  Haemorrhoids - a collagen disease?

Authors:  S Willis; K Junge; R Ebrahimi; A Prescher; V Schumpelick
Journal:  Colorectal Dis       Date:  2010-12       Impact factor: 3.788

8.  The pathogenesis of hemorrhoids.

Authors:  P A Haas; T A Fox; G P Haas
Journal:  Dis Colon Rectum       Date:  1984-07       Impact factor: 4.585

Review 9.  Hemorrhoids, fissures, and pruritus ani.

Authors:  W P Mazier
Journal:  Surg Clin North Am       Date:  1994-12       Impact factor: 2.741

10.  Ehlers-danlos syndrome-hypermobility type and hemorrhoids.

Authors:  Timothy P Plackett; Edward Kwon; Ronald A Gagliano; Robert C Oh
Journal:  Case Rep Surg       Date:  2014-04-15
View more
  17 in total

1.  Offering HeLP to work out the optimum treatment for haemorrhoidal disease.

Authors:  Steven R Brown; Matthew J Lee
Journal:  Tech Coloproctol       Date:  2018-09-14       Impact factor: 3.781

2.  Burden and Cost of Outpatient Hemorrhoids in the United States Employer-Insured Population, 2014.

Authors:  Jeff Y Yang; Anne F Peery; Jennifer L Lund; Virginia Pate; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2019-05       Impact factor: 12.045

3.  Correlation Between Poor Defecation Habits and Postoperative Hemorrhoid Recurrence.

Authors:  Qing Li; Roshan Ara Ghoorun; Li Li; Heng Zhang; Dan Zhang; Haihua Qian; Dong-Lin Ren; Dan Su
Journal:  Front Surg       Date:  2022-06-17

4.  Ischemic proctitis after low-dose-rate brachytherapy using hydrogel spacer for prostate cancer.

Authors:  Ren Toriumi; Hiroshi Yaegashi; Takayuki Sakurai; Shigeyuki Takamatsu; Kazuyoshi Shigehara; Kouji Izumi; Yoshifumi Kadono; Atsushi Mizokami
Journal:  IJU Case Rep       Date:  2022-04-12

5.  Diverticulosis Is Associated With Internal Hemorrhoids on Colonoscopy: Possible Clues to Etiology.

Authors:  J A Sninsky; J Galanko; R S Sandler; Anna F Peery
Journal:  Clin Gastroenterol Hepatol       Date:  2022-02-14       Impact factor: 13.576

6.  Non-Doppler hemorrhoidal artery ligation and hemorrhoidopexy combined with pudendal nerve block for the treatment of hemorrhoidal disease: a non-inferiority randomized controlled trial.

Authors:  Konstantinos Perivoliotis; Michail Spyridakis; Elias Zintzaras; Eleni Arnaoutoglou; Manousos-Georgios Pramateftakis; Konstantinos Tepetes
Journal:  Int J Colorectal Dis       Date:  2020-10-06       Impact factor: 2.571

7.  Portuguese Society of Gastroenterology Consensus on the Diagnosis and Management of Hemorrhoidal Disease.

Authors:  Paulo Salgueiro; Ana Célia Caetano; Ana Maria Oliveira; Bruno Rosa; Miguel Mascarenhas-Saraiva; Paula Ministro; Pedro Amaro; Rogério Godinho; Rosa Coelho; Rúben Gaio; Samuel Fernandes; Vítor Fernandes; Fernando Castro-Poças
Journal:  GE Port J Gastroenterol       Date:  2019-09-05

8.  How is your proctology patient really doing? Outcome measurement in proctology: development, design and validation study of the Proctoprom.

Authors:  G J Vander Mijnsbrugge; C Molenaar; R Buyl; G Westert; P J van der Wees
Journal:  Tech Coloproctol       Date:  2020-02-28       Impact factor: 3.781

9.  Genome-wide analysis of 944 133 individuals provides insights into the etiology of haemorrhoidal disease.

Authors:  Tenghao Zheng; David Ellinghaus; Simonas Juzenas; Clemens Schafmayer; Mauro D'Amato; Andre Franke; François Cossais; Greta Burmeister; Gabriele Mayr; Isabella Friis Jørgensen; Maris Teder-Laving; Anne Heidi Skogholt; Sisi Chen; Peter R Strege; Go Ito; Karina Banasik; Thomas Becker; Frank Bokelmann; Søren Brunak; Stephan Buch; Hartmut Clausnitzer; Christian Datz; Frauke Degenhardt; Marek Doniec; Christian Erikstrup; Tõnu Esko; Michael Forster; Norbert Frey; Lars G Fritsche; Maiken Elvestad Gabrielsen; Tobias Gräßle; Andrea Gsur; Justus Gross; Jochen Hampe; Alexander Hendricks; Sebastian Hinz; Kristian Hveem; Johannes Jongen; Ralf Junker; Tom Hemming Karlsen; Georg Hemmrich-Stanisak; Wolfgang Kruis; Juozas Kupcinskas; Tilman Laubert; Philip C Rosenstiel; Christoph Röcken; Matthias Laudes; Fabian H Leendertz; Wolfgang Lieb; Verena Limperger; Nikolaos Margetis; Kerstin Mätz-Rensing; Christopher Georg Németh; Eivind Ness-Jensen; Ulrike Nowak-Göttl; Anita Pandit; Ole Birger Pedersen; Hans Günter Peleikis; Kenneth Peuker; Cristina Leal Rodriguez; Malte Christoph Rühlemann; Bodo Schniewind; Martin Schulzky; Jurgita Skieceviciene; Jürgen Tepel; Laurent Thomas; Florian Uellendahl-Werth; Henrik Ullum; Ilka Vogel; Henry Volzke; Lorenzo von Fersen; Witigo von Schönfels; Brett Vanderwerff; Julia Wilking; Michael Wittig; Sebastian Zeissig; Myrko Zobel; Matthew Zawistowski; Vladimir Vacic; Olga Sazonova; Elizabeth S Noblin; Gianrico Farrugia; Arthur Beyder; Thilo Wedel; Volker Kahlke
Journal:  Gut       Date:  2021-04-22       Impact factor: 23.059

10.  Management of haemorrhoids: protocol of an umbrella review of systematic reviews and meta-analyses.

Authors:  Min Chen; Tai-Chun Tang; Tao-Hong He; Yong-Jun Du; Di Qin; Hui Zheng
Journal:  BMJ Open       Date:  2020-03-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.